Ra Medical Systems (RMED) Stock Price, News & Analysis

Company Overview

Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.54 to $1.10
• 52-Week Range: N/A
• Volume: 77,500 shs
• Average Volume: 197,480 shs
• Market Capitalization: $3.19 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RMED Stock Analysis - Frequently Asked Questions

How were Ra Medical Systems' earnings last quarter?

Ra Medical Systems, Inc (NYSE:RMED) released its quarterly earnings data on Monday, November, 15th. The company reported ($57.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($39.50) by $18.00. The company had revenue of $0.01 million for the quarter, compared to analysts' expectations of $0.70 million.

When did Ra Medical Systems' stock split?

Ra Medical Systems's stock reverse split before market open on Monday, October 3rd 2022.The 1-50 reverse split was announced on Monday, October 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

When did Ra Medical Systems IPO?

Ra Medical Systems (RMED) raised $50 million in an initial public offering (IPO) on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor served as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

What other stocks do shareholders of Ra Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ra Medical Systems investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), Corbus Pharmaceuticals (CRBP), NIO (NIO), Vaxart (VXRT), iBio (IBIO) and Pfizer (PFE).

Company Calendar

• Last Earnings: 11/15/2021
• Today: 8/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NYSE:RMED
• CIK: 1716621
• Web: www.ramed.com
• Phone: (973) 691-2000
• Fax: N/A
• Employees: 14
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($92.36)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$26.86 million
• Net Margins: N/A
• Pretax Margin: -97,518.88%
• Return on Equity: -496.57%
• Return on Assets: -344.49%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.86
• Quick Ratio: 2.85

Sales & Book Value

• Annual Sales: $10 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.29 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 5,370,000
• Free Float: 4,368,000
• Market Cap: $3.19 million
• Optionable: Not Optionable
• Beta: -0.03